Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Almila, Ulpu
DOB: 03-SEP-1993 (Age: 32)
Gender: female
Address:
Viru 51
94764 Tupenurme (Estonia)
ID: 9847-452473-7
Report
Date: 09-APR-2023
Laboratory
Requested by
Emmaste Kliinik
92412 Hiiumaa vald (Estonia)
Specimen
Collected: 08-APR-2023

Chemistry

Test 08 Apr 2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 H 4.6 - 5.6 %
Glucose [Mass/volume] in Blood 68.5 L 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.9 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.3 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.1 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.1 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.3 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Hemoglobin A1c is mildly elevated, suggesting possible impaired glucose tolerance or early prediabetes, despite a slightly low fasting glucose. Renal function, electrolytes, and other parameters are within normal limits. Recommend clinical correlation for glycemic status and consideration of repeat or additional testing for glucose metabolism.